World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
29276
World Ranking
15485
National Ranking
599

Roberto Orecchia publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roberto Orecchia sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 909 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Roberto Orecchia D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto Orecchia sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Roberto Orecchia is affiliated with the European Institute of Oncology in Italy, contributing extensively to the field of medicine with a focus on oncology and radiotherapy. Their research encompasses numerous aspects of cancer treatment, particularly in radiotherapy and breast cancer management.

The scientist has published work in a variety of high-impact venues, with frequent contributions to:

  • Radiotherapy and Oncology
  • Cancers
  • Physica Medica
  • Tumori Journal
  • Frontiers in Oncology

Orecchia's research covers several primary fields within medicine, including:

  • Pulmonary and Respiratory Medicine
  • Radiology, Nuclear Medicine and Imaging
  • Cancer Research
  • Radiation
  • Oncology

Their work frequently addresses the following main topics:

  • Advanced Radiotherapy Techniques
  • Breast Cancer Treatment Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Prostate Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Radiation Therapy and Dosimetry
  • Prostate Cancer Treatment and Research

Notable recent publications include:

  • Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations, 2020, Annals of Oncology
  • Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes, 2023, JAMA Oncology
  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group, 2021, Radiotherapy and Oncology
  • Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial, 2021, The Lancet Oncology
  • Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy, 2020, Frontiers in Oncology

Frequently collaborating researchers include:

  • Barbara Alicja Jereczek-Fossa
  • Giulia Marvaso
  • Federica Cattani
  • Mattia Zaffaroni
  • Stefania Volpe

Best Publications

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.

    Francesco Sardanelli;Carla Boetes;Bettina Borisch;Thomas Decker

  • Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    F. A. Peccatori;H. A. Azim;R. Orecchia;Harald Hoekstra

  • Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Patrick Maisonneuve;Giuseppe Viale;Giuseppe Viale

  • Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

    Giuseppe Curigliano;Daniel J. Lenihan;Michael G. Fradley;Sarju Ganatra

  • Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.

    Tadashi Kamada;Hirohiko Tsujii;Eleanor A Blakely;Jürgen Debus

  • Very young women (<35 years) with operable breast cancer: features of disease at presentation

    M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando

  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

    Viviana Galimberti;Bernard F Cole;Giuseppe Viale;Giuseppe Viale;Paolo Veronesi;Paolo Veronesi

  • Charged-particle therapy in cancer: clinical uses and future perspectives

    Marco Durante;Roberto Orecchia;Jay S. Loeffler

  • A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated.

    U Veronesi;R Orecchia;A Luini;G Gatti

  • Radiotherapy-Induced Mandibular Bone Complications

    Barbara A. Jereczek-Fossa;Barbara A. Jereczek-Fossa;Roberto Orecchia;Roberto Orecchia

  • Radiotherapy-induced thyroid disorders.

    Barbara A Jereczek-Fossa;Daniela Alterio;Jacek Jassem;Bianca Gibelli

  • Radiotherapy-related fatigue.

    Barbara Alicja Jereczek-Fossa;Barbara Alicja Jereczek-Fossa;Hugo Raul Marsiglia;Roberto Orecchia;Roberto Orecchia

  • Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Alberto Luini;Alberto Luini;Viviana Galimberti

  • Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis

    Piet Ost;Barbara Alicja Jereczek-Fossa;Nicholas Van As;Thomas Zilli

  • Breast carcinoma in elderly women: Features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients

    Roberto Gennari;Giuseppe Curigliano;Nicole Rotmensz;Chris Robertson

  • Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO)

    J. Y. Petit;U. Veronesi;R. Orecchia;P. Rey

  • Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.

    Barbara Alicja Jereczek-Fossa;Barbara Alicja Jereczek-Fossa;Giancarlo Beltramo;Laura Fariselli;Cristiana Fodor

  • Radiotherapy-induced ear toxicity.

    Barbara A Jereczek-Fossa;Andrzej Zarowski;Franco Milani;Roberto Orecchia;Roberto Orecchia

  • Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

Frequent Co-Authors

Paolo Veronesi
Paolo Veronesi European Institute of Oncology
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Viviana Galimberti
Viviana Galimberti European Institute of Oncology
Giuseppe Viale
Giuseppe Viale University of Milan
Nicole Rotmensz
Nicole Rotmensz European Institute of Oncology
Giuseppe Curigliano
Giuseppe Curigliano University of Milan
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Alberto Luini
Alberto Luini National Research Council (CNR)
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Vincenzo Bagnardi
Vincenzo Bagnardi University of Milano-Bicocca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in exploring alternative pathways or advancing your career in healthcare, there are many flexible online degrees available. For nurses seeking to become leaders in clinical settings, the easiest online DNP programs offer advanced practice training while allowing you to balance work and study.

Those wishing to enter the nursing profession quickly can consider a 6 month LPN program online. These programs provide fast-track routes to secure licensure and start working in entry-level nursing roles with minimal delay.

Mental health is a rapidly growing field. For registered nurses aiming to specialize, psych NP online programs offer a focused curriculum in psychiatric-mental health, often with accelerated options available.

If you're seeking a non-clinical leadership career, an online health management degree could be the right fit. These programs equip you with essential business, policy, and organizational skills for managing healthcare facilities.

Best Scientists Citing Roberto Orecchia

Trending Scientists

Recently Published Articles